Assignee
AKESO PHARMACEUTICALS INC
CN·2 granted patents·3 pending applications·7 citations·filing 2017–2024
Top patents by PatentIndex Score
5 records- 0191US11578128B2Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO PHARMACEUTICALS INC·Filed 2017·Granted Feb 14, 2023·7 cites·29 claims
- 0273US12479919B2Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO PHARMACEUTICALS INC·Filed 2022·Granted Nov 25, 2025·0 cites·22 claims
- 0362US2025188164A1Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and chiauranibAKESO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0454US2024199741A1Use of antibody in anti-tumor treatmentAKESO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0549US2022275089A1Anti-ctla4-anti-pd-1 bispecific antibody and uses thereofAKESO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AKESO PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →